Dualitas Therapeutics Announces Proximity Biology Research Collaboration with Roche to Discover and Develop Novel Bispecific Antibodies for I&I Diseases

<p>Dualitas will use its DualScreen™ Bispecific Discovery Engine to functionally screen more than 300,000 novel bispecific combinations for Immunology & Inflammation (I&I) diseases – representing one of the largest-scale bispecific discovery endeavors Collaboration leverages Dualitas'...</p>